Internal Medicine, Infectious Disease · Minneapolis, MN
NPI
1477594588
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
701 Park Ave
Minneapolis, MN, 55415
Phone (612) 873-6963
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
315 services
Medicare patients, 2024
81
Average age 60
Drug cost, 2024
$4.1M
4,317 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald L Schut was code 99214 (office e&m - established), 95 times for 46 patients. In total Ronald L Schut billed 315 services in 18 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 95 | 46 | $60.96 | $5,792 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 93 | 38 | $11.67 | $1,085 |
| 99232 Hospital E&M - Subsequent | Facility | 44 | 19 | $57.16 | $2,515 |
| 99213 Office E&M - Established | Facility | 25 | 19 | $49.46 | $1,237 |
By year: 2022 $17K for 250 services; 2023 $14K for 207 services; 2024 $15K for 315 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ronald L Schut prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 359 prescriptions and refills. In total Ronald L Schut wrote 4,317 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 359 | 359 | 44 | $1.4M |
| Tivicay Dolutegravir Sodium | 188 | 188 | 24 | $453K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 140 | 140 | 16 | $531K |
| Atorvastatin Calcium Generic | 128 | 148 | 16 | $498 |
| Gabapentin Generic | 127 | 139 | 16 | $1,169 |
| Valacyclovir Valacyclovir Hcl | 123 | 131 | 15 | $3,869 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 123 | 123 | 13 | $462K |
| Losartan Potassium Generic | 103 | 118 | 14 | $698 |
| Omeprazole Generic | 101 | 121 | 15 | $505 |
| Amlodipine Besylate Generic | 98 | 106 | 13 | $348 |
| Zolpidem Tartrate Generic | 87 | 87 | Under 11 | $238 |
| Descovy Emtricitabine/Tenofov Alafenam | 86 | 86 | 12 | $191K |
| Tamsulosin Hcl Generic | 81 | 85 | 12 | $326 |
| Ventolin Hfa Albuterol Sulfate | 77 | 77 | 18 | $3,552 |
| Lisinopril Generic | 74 | 89 | Under 11 | $487 |
Brand drugs: 1,472 claims; generic drugs: 2,810 claims; opioid claims: 161.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Ronald L Schut were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.